HNB
IRWD icon

Huntington National Bank’s Ironwood Pharmaceuticals IRWD Stock Holding History

Huntington National Bank’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-92
Closed -$408 – 4202
2024
Q4 		$408 Buy
92
+22
+31% +$89 ﹤0.01% 2535
2024
Q3 		$288 Buy
+70
New +$376 ﹤0.01% 2587
2024
Q2 		– Sell
-93
Closed -$810 – 4134
2024
Q1 		$810 Buy
+93
New +$1.13K ﹤0.01% 2310
2023
Q3 		– Sell
-432
Closed -$4.6K – 3866
2023
Q2 		$4.6K Buy
432
+23
+6% +$247 ﹤0.01% 1840
2023
Q1 		$4.3K Buy
+409
New +$4.58K ﹤0.01% 1771

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Huntington National Bank's IRWD Position: Q1 2025 in Review

Huntington National Bank sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 92 shares — an estimated $408 sold.

Huntington National Bank first reported a position in IRWD in Q1 2023 and held it in 5 quarters. The position peaked at $4.6K in Q2 2023. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Huntington National Bank reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Huntington National Bank sold 92 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $408.
  • Huntington National Bank first reported a position in Ironwood Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • Huntington National Bank's Ironwood Pharmaceuticals position peaked at $4.6K in Q2 2023.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Huntington National Bank's 13F filing for Q1 2025, filed 14 May 2025.